This makes Pfizer a potentially cheap stock to buy while collecting a solid dividend. It's generated about $14 billion in ...

Pfizer's stock is down roughly 60% from its late 2021 highs, but the drug giant is working to innovate its way back into the ...

The cost of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the drugmakers pledging to offer more favorable prices under new Trump ...

According to healthcare research firm 3 Axis Advisors, drugmakers are planning to raise U.S. prices on medications including ...

How $2,670 split across three durable high-yield stocks can generate $300 in annual dividends without risky payouts.

A great dividend stock is one that's supported by a financially healthy, stable, and mature company with a proven commitment ...

GSK (GSK) and other leading drugmakers plans to raise prices of as many as 350 medicines next year, with a median hike of ...

More medicines are slated for price hikes in 2026, with increases tracking around recent inflation levels. ・Only a few drugs ...

From prescriptions to hospitals to Medicaid, President Donald Trump's healthcare vision, with eligibility changes, will come ...

Drugmakers plan to raise U. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and ...

On December 16, Pfizer Inc. (NYSE:PFE) said the next few years are expected to be bumpy, starting in 2026. The company ...

Medicine is expensive and only seems to get more so every year. But this doesn’t have to be inevitable. The reason patients ...